THE NEONATAL IMMUNE SYSTEM

ESPID Education, Sing Sing Way, 218734

ASSOCIATION BETWEEN THE SAFE DELIVERY APP AND QUALITY OF CARE AND PERINATAL SURVIVAL IN ETHIOPIA: A RANDOMIZED CLINICAL TRIAL

ESPID Education, Stine Lund, 218733

SEPSIS PREVENTION AMONG INFANTS IN RURAL INDIA

ESPID Education, Pinaki Panigrahi, 218732

POLIO ERADICATION

ESPID Education, Hamid Jafari, 218731

BAYESIAN ANALYSIS OF S. TYPHI STRAINS FROM NEPALI CHILDREN REVEAL CHANGES IN THE PATHOGEN POPULATION STRUCTURE WITH IMPLICATIONS FOR ANTIMICROBIAL TREATMENT REGIMENS AND VACCINE POLICY

ESPID Education, Carl Britto, 218724

ANCIENT DNA & OUTBREAKS

ESPID Education, Eske Willerslev, 218722

THE CRISPR STORY

ESPID Education, Marco Herold, 218721

SYSTEMIC AND INTRATHECAL IMMUNE ACTIVATION IN PERINATALLY HIV-INFECTED CHILDREN

ESPID Education, Charlotte Blokhuis, 179700

Treatment of MDR-TB

ESPID Education, H. Simon Schaaf, 179695

Kawasaki Disease

ESPID Education, Rolando Ulloa-Gutierrez, 179699

TB diagnostics for children

ESPID Education, Marc Tebruegge, 179694

When the immune system looses control- Dysregulation due to CTLA4 and LRBA deficiency

ESPID Education, David Sansom, 179698

In the search of a new TB vaccine

ESPID Education, Carlos Martin, 179693

Monogenic causes of immune dysregulation

ESPID Education, Juantxo Aróstegui, 179697

CEREBROSPINAL FLUID B-LYMPHOCYTE CHEMOATTRACTANT CXCL 13 IN THE DIAGNOSIS OF ACUTE LYME NEUROBORRELIOSIS IN CHILDREN

ESPID Education, Bjørn Barstad, 179692

THE CLINICAL SYNDROMES AND OUTCOMES ASSOCIATED WITH INVASIVE GROUP A STREPTOCOCCAL (IGAS) INFECTIONS IN BRISTOL FROM 2006-2015.

ESPID Education, Natasha Daoud, 179687

APPLICATION OF A 2-TRANSCRIPT RNA SIGNATURE TO DISCRIMINATE BACTERIAL FROM VIRAL INFECTION IN YOUNG INFANTS USING DIVERSE RNA QUANTITATION PLATFORMS

ESPID Education, Jethro Herberg, 179691

MULTI-CENTER STUDY EVALUATING INCIDENCE, PREDISPOSING FACTORS AND CLINICAL CHARACTERISTICS OF PEDIATRIC INVASIVE GROUP A STREPTOCOCCAL DISEASE IN MADRID, SPAIN

ESPID Education, Lucia Marcela Figueroa Ospina, 179686

A NOVEL HOST-PROTEIN SIGNATURE OUTPERFORMS STANDARD LABORATORY PARAMETERS IN DIFFERENTIAL DIAGNOSIS OF ACUTE INFECTION ETIOLOGY OF FEBRILE CHILDREN

ESPID Education, Isaac Srugo, 179690

Will we have the first GAS vaccine at the horizon 2020?

ESPID Education, Andrew Steer, 179685

GWAS in children

ESPID Education, Mike Levin, 179689

Epidemiology: GAS disease in Europe and in the world in 10 questions

ESPID Education, Pierre Smeesters, 179683

Transcriptomics: Clinical applications in Infectious Diseases

ESPID Education, Octavio Ramilo, 179688

Paediatric HIV: The European Contribution

ESPID Education, Carlo Giaquinto, 179682

RSV disease severity: Insights into protective host immune responses

ESPID Education, Santtu Heinonen, 179681

ESPID Young Investigator Award 2017 Ceremony: Cerebral Malaria - Clotting and broken barriers in the brain

ESPID Education, Christopher Moxon, 179679

ESPID Young Investigator Award 2017 Ceremony: B Cell responses and beyond - Johannes Trück

ESPID Education, Pierre Smeesters, 179676

ESPID Education and Communication Award Ceremony

ESPID Education, Shai Ashkenazi, 179670

A MULTIPLE ANTIGEN PRESENTING SYSTEM (MAPS) VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS PULMONARY INFECTION

ESPID Education, Rick Malley, 179669

THE IMPACT OF AGE AT VACCINATION ON INFANT VACCINE RESPONSES: AN ANALYSIS OF IMMUNITY IN 7630 CHILDREN

ESPID Education, Merryn Voysey, 179668

Systems vaccinology

ESPID Education, Rafick-Pierre Sekaly, 179667

Reverse vaccinology

ESPID Education, Rino Rappuoli, 179666

Why infections in different places need different vaccine programmes

ESPID Education, B. Gessner, 179665

PHARMACOKINETICS, SAFETY AND EFFICACY OF OMBITASVIR/PARITAPREVIR/RITONAVIR ± DASABUVIR ± RIBAVIRIN IN HEPATITIS C GENOTYPE 1 OR 4 VIRUS INFECTED ADOLESCENTS: THE ZIRCON STUDY

ESPID Education, Stefan Wirth, 179649

BUNDLE APPROACH TO REDUCE VENTILATOR ASSOCIATED PNEUMONIA IN NEONATES: A QUALITY IMPROVEMENT INITIATIVE IN AN OUTBORN NICU OF DELHI.

ESPID Education, Mamta Jajoo, 179659

MMR AND INFLUENZA VACCINATION COVERAGE AMONG MIGRANT CHILDREN IN FINLAND – A REGISTER-BASED STUDY

ESPID Education, Paula Tiittala, 179664

TRANSIENT TACHYPNEA OF THE NEWBORN IS ASSOCIATED WITH INCREASED RISK OF BRONCHIOLITIS IN INFANTS

ESPID Education, Otto Helve, 179653

LATENT TUBERCULOSIS INFECTION IN YOUNG REFUGEES AND ASYLUM SEEKING MIGRANTS; A MULTICENTRE CROSS-SECTIONAL STUDY

ESPID Education, Maya Mueller-Hermelink, 179663

IMMUNOGENICITY OF DIFFERENT DOSING SCHEDULES OF TRIVALENT INFLUENZA VACCINE IN HIV-INFECTED PREGNANT WOMEN: A RANDOMIZED CONTROLLED TRIAL

ESPID Education, Marta S.C. Nunes, 179652

FIRST OUTBREAK OF ENTEROVIRUS RELATED BRAINSTEM ENCEPHALITIS IN WESTERN EUROPE: CHARACTERIZATION, MANAGEMENT AND EVOLUTION OF THE PATIENTS

ESPID Education, Núria Worner Tomasa, 179647

IMMUNOLOGICAL RESPONSE TO TREATMENT IN HIV-INFECTED MIGRANT CHILDREN IN EUROPE AS COMPARED TO DOMESTIC-BORN COUNTERPARTS

ESPID Education, Malte Kohns, 179662

IMPACT OF A CARBAPENEM ANTIMICROBIAL STEWARDSHIP PROGRAMME ON PATIENT OUTCOMES IN A WOMEN’S AND CHILDREN’S HOSPITAL

ESPID Education, Xue Fen Valerie Seah, 179656

New respiratory viruses

ESPID Education, Adam Meijer, 179646

Vaccination programmes in refugee camps

ESPID Education, Markus Hufnagel, 179661

Treatment of MDR enterobacteria

ESPID Education, Jesús Rodríguez-Baño, 179655

Enterovirus/parechovirus

ESPID Education, Heli Harvala, 179645

Immunisation during pregnancy

ESPID Education, Flor Muñoz, 179650

Antimicrobial stewardship in children

ESPID Education, Theoklis Zaoutis, 179654

Antibiotic-resistant pathogens in refugee children

ESPID Education, Daniel Glikman, 179660

MARKERS OF RISK TO DEVELOP A SEVERE INFECTION IN CHILDREN WITH FEVER AND NEUTROPENIA RELATED TO CHEMOTHERAPY

ESPID Education, Jesus Saavedra-Lozano, 179638

ANTIBODY ADMINISTRATION EFFECTIVELY TREATS PERTUSSIS IN A BABOON DISEASE MODEL AND PROVIDES FIVE WEEKS OF PERTUSSIS PROPHYLAXIS IN NEWBORN BABOONS

ESPID Education, Jennifer Maynard, 179644

EARLY TREATMENT OF CHAGAS DISEASE PREVENTS CONGENITAL TRANSMISSION.

ESPID Education, Jaime Altcheh, 184348

VIRAL KINETICS AND TREATMENT OF CYTOMEGALOVIRUS INFECTIONS IN IMMUNOCOMPROMISED CHILDREN

ESPID Education, Ben Margetts, 179637

NEGATIVE CYTOMEGALOVIRUS PCR IN NEONATAL DRIED BLOOD SPOTS: CAN WE RULE CONGENITAL INFECTION OUT? A STUDY FROM THE SPANISH REGISTRY (REDICCMV)

ESPID Education, Isabel Vives-Oñós, 179627

MOLECULAR BACTERIOLOGICAL SURVEILLANCE OF PAEDIATRIC ENTERIC FEVER IN NEPAL BETWEEN 2008 AND 2015

ESPID Education, Carl Britto, 179631

PERTUSSIS ANTIBODIES IN ENTIRE POPULATION, AMONG PATIENTS WITH PERTUSSIS AND THE TIME COURSE UP TO THREE YEARS AFTER THE DISEASE

ESPID Education, Piia Jõgi, 179642

CLINICAL AND MICROBIOLOGICAL CHARACTERIZATION OF INVASIVE VIRIDANS GROUP STREPTOCOCCI INFECTIONS IN CHILDREN WITH CANCER, FEVER AND NEUTROPENIA, SANTIAGO, CHILE, 2004-2015

ESPID Education, María Carolina Rivacoba Rojas, 179635

Immunsing pregnant women – success and challenges

ESPID Education, Gayatri Amirthalingam, 179641

Congenital CMV

ESPID Education, Tiziana Lazzarotto, 179626

Viral infection in the child with HSCT

ESPID Education, Janet Englund, 179634

The search for a better pertussis vaccine

ESPID Education, Camille Locht, 179640

Typhoid disease burden

ESPID Education, John Crump, 179629

Risk factors in the neutropenic child

ESPID Education, Maria Elena Santolaya, 179633

Global Pertussis Initiative

ESPID Education, Stanley Plotkin, 179639

Future treatments for early treated HIV-infected children

ESPID Education, Jintanat Ananworanich, 179623

Immunological characteristics in early treated HIV-infected children

ESPID Education, Nigel Klein, 179622

Multi-level microbial biology in the light of evolution

ESPID Education, Fernando Baquero, 179619

DESCRIPTION OF PREVALENCE OF SYMPTOMS RELATED ZIKA VIRUS IN PREGNANT WOMEN WITH CHILDREN WITH MICROCEPHALY DURING THE FIRST YEAR OF EPIDEMIC IN PERNAMBUCO/BRAZIL

ESPID Education, Luiza Mello, 179617

Zika

ESPID Education, Karin Nielsen, 179616

Dengue

ESPID Education, Elisabeth Barnett, 179615

Chinkungunya

ESPID Education, Marco Safadi, 179614

INCREASING VACCINE COVERAGE - BARRIERS AND ATTITUDES

ESPID Education, Robb Butler, 134427

GETTING VACCINATED - ACCESS AND ATTITUDES

ESPID Education, Irina Ljungqvist, 134426

COMPARISON OF CHILDREN TESTING NEGATIVE AND POSITIVE FOR EBOLA VIRUS DISEASE IN EBOLA HOLDING UNITS, SIERRA LEONE

ESPID Education, Felicity Fitzgerald, 132227

RTSS MALARIA VACCINE., DOES IT WORK? IS IT SAFE?

ESPID Education, Brian Greenwood, 132228

TO LP OR NOT TO LP: SAFETY OF LUMBAR PUNCTURE IN COMATOSE CHILDREN WITH CLINCIAL FEATURES OF CEREBRAL MALARIA

ESPID Education, Christopher Moxon, 132229

REFUGEES ARRIVING IN EUROPE: THE MUNICH PAEDIATRIC INFECTION EXPERIENCE

ESPID Education, Ulrich von Both, 132230

VACCINE HESITANCY - THE EMERGENCE OF GLOBAL MISUNDERSTANDING

ESPID Education, Emilie Karafillakis, 134428

RSV - NEW THERAPEUTIC HORIZONS BRING CLINICAL CHALLENGES

ESPID Education, Steve Cunningham, 132215

SEASONAL AND PANDEMIC INFLUENZA IN PAEDIATRIC INTENSIVE CARE UNITS IN ENGLAND AND WALES: RISK FACTORS FOR ADMISSION AND MORTALITY

ESPID Education, Pia Hardelid, 132216

DIAGNOSIS AND PATHOPHYSIOLOGY OF BIOFILM INFECTIONS IN CYSTIC FIBROSIS

ESPID Education, Niels Hoeiby, 132217

DEXAMETHASONE FOR PLEURAL INFECTION IN CHILDREN: A DOUBLE BLIND, RANDOMIZED, CLINICAL TRIAL OF EFFICACY AND SAFETY

ESPID Education, ALFREDO TAGARRO, 132218

NASOPHARYNGEAL BACTERIAL DENSITY IS INCREASED BY VIRAL RESPIRATORY INFECTIONS WHICH MAY FACILITATE TRANSMISSION

ESPID Education, Valtyr Thors, 132219

HIGHLIGHTS & LESSONS FROM THE FIRST 17 YEARS OF THE BRIGHTON COLLABORATION

ESPID Education, Jan Bonhoeffer, 132220

ENHANCING VACCINE SAFETY CAPACITY GLOBALLY: A LIFECYCLE PERSPECTIVE

ESPID Education, Robert Chen, 132221

NO ASSOCIATION OF THE TEN-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV10) WITH PREVIOUSLY SUGGESTED PCV SAFETY SIGNALS

ESPID Education, Arto A Palmu, 132222

INFLUENZA VACCINATION IN CHILDREN WITH CYSTIC FIBROSIS USING INTRANASAL LIVE ATTENUATED INFLUENZA VACCINE: EXPERIENCE FROM AN AUSTRIAN PAEDIATRIC HOSPITAL

ESPID Education, Sabine Renner, 132223

EXPLORING INCIDENCE RATES OF GUILLIAIN BARR

ESPID Education, Jozica Skufca, 132224

MEASUREMENT OF FEVER AFTER INFANT IMMUNISATIONS: COMPARISON OF INTERMITTENT AND 24 HOURS CONTINUOUS MONITORING

ESPID Education, Marta Valente Pinto, 132225

USING SMS TECHNOLOGY FOR REAL-TIME SURVEILLANCE OF ADVERSE EVENTS FOLLOWING IMMUNISATION

ESPID Education, Darren Westphal, 132226

THE RESURGENCE OF PERTUSSIS: FACTS, FICTION, MYTHS AND MISCONCEPTIONS?

ESPID Education, James Cherry, 132214

BILL MARSHALL LECTURE & AWARD: INTRODUCTION

ESPID Education, Adam Finn, 135835

ESCAPETB PROJECT -ENVIRONMENTAL SURVEILLANCE IN CANADA AND CAPE TOWN - IMPROVING OUR UNDERSTANDING OF AIRBORNE PATHOGEN EXPOSURE WITH A FOCUS ON TRANSMISSION OF ROD-SHAPED (MYCO-)BACTERIA)

ESPID Education, Koen Vanden Driessche, 132208

DISCOVERY OF IMMUNODOMINANT B CELL EPITOPES WITHIN SURFACE PNEUMOCOCCAL VIRULENCE PROTEINS IN PEDIATRIC PATIENTS WITH INVASIVE PNEUMOCOCCAL DISEASE

ESPID Education, Theano Lagousi, 132206

IMMUNOGENICITY OF REDUCED DOSE PRIMING SCHEDULES OF SEROGROUP C MENINGOCOCCAL CONJUGATE VACCINE FOLLOWED BY BOOSTER AT 12 MONTHS IN INFANTS: OPEN LABEL RANDOMISED CONTROLLED TRIAL

ESPID Education, David Pace, 132205

HOW DOES THE GUT-MICROBIOTA INFLUENCE THE ONSET AND NATURE OF JUVENILE IDIOPATHIC ARTHRITIS?

ESPID Education, Paula Sanchez-Moreno, 132203

ZIKA VÍRUS AND GESTATION: FIRST CASES DETECTED IN SERGIPE

ESPID Education, Eitan Berezin, 132197

EARLY ANTIRETROVIRAL THERAPY PRESERVES THYMIC OUTPUT IN CHILDREN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS: EVIDENCE FROM THE CHILDREN WITH HIV EARLY ANTIRETROVIRAL THERAPY (CHER) TRIAL

ESPID Education, Helen Payne, 132198

PROTECTING AGAINST THE CHANGELING DEMON AND THE TROLL OF TRANSPLANTATION

ESPID Education, Stanley Plotkin, 132199

CLINICAL SIGNS AND POINT OF CARE TESTING IN FEBRILE CHILDREN

ESPID Education, Henriette Moll, 132183